Literature DB >> 15060767

[Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

D Reske1, H-F Petereit.   

Abstract

A number of neurological syndromes may be evoked by involvement of the nervous system due to systemic diseases such as lupus erythematosus, sarcoidosis, Behcet's disease, and Sjogren's syndrome. Because of different treatment strategies, it is important to distinguish between these different diseases. Neither clinical signs nor additional analyses such as serological findings or cerebrospinal fluid analysis are able to differentiate between the diseases with certainty. Nevertheless, diagnosis may finally be made taking all findings together. Here we compare typical clinical and cerebrospinal fluid findings in neurosarcoidosis, neurolupus, neuro-Behcet, and nervous system involving Sjogren's syndrome, with special emphasis on those findings allowing differentiation of the respective diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15060767     DOI: 10.1007/s00115-004-1699-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  62 in total

Review 1.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  Aseptic meningoencephalitis in primary Sjögren's syndrome.

Authors:  E L Alexander; G E Alexander
Journal:  Neurology       Date:  1983-05       Impact factor: 9.910

3.  Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; D L Cookfair; N A Simonian; R M Ransohoff; J R Richert; L D Jacobs; R M Herndon; A M Salazar; J S Fischer; C V Granger; D E Goodkin; J H Simon; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; M E Coats; S L Cohan; D S Dougherty; R P Kinkel; M K Mass; F E Munchsauer; K O'Reilly; R L Priore; R H Whitham
Journal:  J Neuroimmunol       Date:  1999-01-01       Impact factor: 3.478

Review 4.  Sarcoidosis of the eye, orbit, and central nervous system. Role of MR imaging.

Authors:  M F Mafee; S Dorodi; E Pai
Journal:  Radiol Clin North Am       Date:  1999-01       Impact factor: 2.303

5.  Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

Authors:  S Hirohata; S Hirose; T Miyamoto
Journal:  Arch Intern Med       Date:  1985-10

6.  Systemic lupus erythematosus. A prospective analysis.

Authors:  R Grigor; J Edmonds; R Lewkonia; B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

Review 7.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations.

Authors:  B J Stern; D E Griffin; R A Luke; A Krumholz; C J Johns
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

9.  Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.

Authors:  F Vartdal; B Vandvik
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

1.  [Revision of McDonald's new diagnostic criteria for multiple sclerosis].

Authors:  H Wiendl; B C Kieseier; R Gold; R Hohlfeld; M Bendszus; H-P Hartung
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

2.  [Differential diagnosis of solitary neurosarcoidosis].

Authors:  J Schelhorn; U Smesny; C Fitzek; M Brodhun; O W Witte; C Terborg
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.